Zhejiang Raybow Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CARBAMAZEPINE PROCESS B, with a corresponding US DMF Number 27261.
Remarkably, this DMF maintains an Active status since its submission on June 21, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 03, 2014, and payment made on November 29, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type IV